Kimia Bio-sciences Limited, originally Laurel Organics Limited, was established in September 1993 and operates in the pharmaceutical industry, focusing on manufacturing bulk drugs and APIs. Located in Gurgaon, Haryana, the facility began operations in 1995 after a public issue to finance the project. The company faced financial difficulties in the late 1990s, becoming classified as a sick industrial unit. However, by 2005, it was deregistered from this status after fully utilizing its capacity for manufacturing intermediate products for Ranbaxy Laboratories, functioning as an ancillary industrial unit.
In 2018, a significant restructuring occurred when Kimia Biosciences Limited was merged with the original company through a reverse merger, making the rebranded entity a consolidated pharmaceutical player. Despite past financial challenges, the company has emerged from insolvency proceedings, maintaining its focus on pharmaceutical manufacturing and demonstrating resilience and adaptability in its operations.
